Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous ...

Scientists at the facility are seeking and developing new drugs that can target and kill the cancer-causing cells that drive ...

Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.

NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.

Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...

Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus ...

Breckenridge Pharmaceutical, Inc., -the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals in the United States, - announced today that the Food and ...

Maggie and Eddie Hanratty were newly married and weeks away from having their first child when doctors discovered a massive ...

With the help of a kind stranger, Bethany is set to fulfil her dream of marrying the love of her life Cameron with a wedding ...

The Neurological and Cognitive Examination Primary Brain Tumor A primary brain tumor can originate from a number of different cells in the brain, such as glial cells (glioma), astrocytes (astrocytoma) ...

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...

DSP-0390 is under clinical development by Sumitomo Pharma and currently in Phase II for Anaplastic Astrocytoma. According to GlobalData, Phase II drugs for Anaplastic Astrocytoma have a 19% phase ...